Ever since the introduction of the Papanicolaou (PAP) smear test was published in 1941 in
American Journal of Obstetrics and Gynecology, PAP test linked with definitive treatment has …

Despite ongoing efforts, sub-Saharan Africa faces a higher cervical cancer burden than
anywhere else in the world. Besides HPV infection, definitive factors of cervical cancer are …

Importance Evidence on the relative benefits and harms of primary high-risk human
papillomavirus (hrHPV) testing is needed to inform guidelines. Objective To inform the US …

Summary Background In May, 2018, the Director-General of WHO issued a global call to
eliminate cervical cancer as a public health problem, which will involve ambitious screening …

Importance A substantial effect of human papillomavirus (HPV) vaccines on reducing HPV-
related cervical disease is essential before modifying clinical practice guidelines in partially …

Despite the fact that hysterectomy is the most common surgical procedure worldwide in
gynecology, national reporting of the incidence rate of gynecological cancers rarely removes …

Background A nonavalent human papillomavirus (HPV) vaccine has been licensed for use
in women and men up to age 45 years in the United States. The cost-effectiveness of HPV …

Objectives: With recent approval of standalone HPV testing and increasing uptake of HPV
vaccination, some have postulated that we are moving toward a “post-Pap” era of cervical …

Cervical cancer is widely preventable through screening, but little is known about the
duration of protection offered by a negative screen in North America. A case–control study …

Failure to follow-up women after abnormal cervical screening could lead to cervical cancers,
yet little is known about adherence to recommended follow-up after abnormal co-testing …